Between January 2023 and December 2024, pathologists at a tertiary-care hospital reviewed 1,000 cases of head and neck squamous cell carcinoma. The retrospective study captured significant demographic skews, distinct anatomical site distributions, and varying rates of p16 expression across both conventional tumors and uncommon histological variants.
In Plain English: The Clinical Takeaway
- What was studied: Researchers analyzed 1,000 confirmed head and neck squamous cell carcinoma cases to understand tumor grades, anatomical locations, and p16 biomarker status.
- Key findings: Most patients were men aged 51 to 70. The oral tongue and larynx were the most frequent primary sites, while over half of the tested histological variants showed p16 positivity.
- Diagnostic caution: Authors emphasized that p16 protein buildup acts only as a preliminary flag, not absolute proof of human papillomavirus without additional molecular testing.
Demographic Breakdown and Anatomical Site Distribution in 1,000 Cases
The patient cohort comprised 832 men and 168 women, with the highest concentration of diagnoses occurring within the 51-to-70 age bracket. When mapping primary tumor sites, the oral tongue emerged as the single most frequent location, accounting for 24.7% of the cohort. Meanwhile, supraglottic and glottic tumors combined made up 29.4% of all diagnoses within the retrospective review.
Histological grading revealed that well-differentiated squamous cell carcinomas dominated the findings at 71.0%. Cervical lymph node metastasis appeared in 147 patients, translating to an overall nodal involvement rate of 14.7%. Moderately differentiated tumors displayed the highest within-grade frequency of nodal spread at 20.4%, showing a statistically significant association between histological grade and nodal metastasis.
| Clinicopathological Parameter | Observation / Count | Percentage / Notes |
|---|---|---|
| Total Cohort Size | 1,000 patients | Retrospective analysis (January 2023 – December 2024) |
| Sex Distribution | 832 men / 168 women | Predominantly male cohort |
| Primary Site: Oral Tongue | 247 cases | Most frequent individual anatomical site (24.7%) |
| Primary Sites: Larynx (Supraglottic & Glottic) | 294 cases | Combined laryngeal burden (29.4%) |
| Histological Grade: Well Differentiated | 710 cases | Predominant grade across the cohort (71.0%) |
| Cervical Lymph Node Metastasis | 147 patients | 14.7% overall; highest in moderately differentiated tumors |
Rare Histological Variants Show Higher P16 Positivity
Out of the total series, researchers isolated 109 cases with suitable tissue for p16 immunohistochemistry, splitting the subset between 50 conventional squamous cell carcinomas and 59 rare histological variants. Among the 59 variants—which included papillary, verrucous, and basaloid architectures—32 cases, or 54.2%, tested positive for p16. Papillary squamous cell carcinoma accounted for the majority of these positive results.
For the 50 conventional squamous cell carcinomas examined via immunohistochemistry, 20 cases or 40.0% showed p16 positivity. Beyond primary tumor characteristics, the review also tracked secondary clinical events. Twenty-five patients presented with second primary malignancies, while 16 patients experienced recurrence during the observation window.
Clinicians Avoid Relying on P16 Markers Alone
Patients undergoing diagnostic evaluation for head and neck lesions must avoid assuming that p16 biomarker positivity alone confirms human papillomavirus infection, particularly in tumors originating outside the oropharynx. Because p16 overexpression can occur independently of viral drivers, clinicians rely on complete pathological reviews rather than isolated immunohistochemical markers.
Global Burden and Diagnostic Implications in South Asia
The findings reflect a heavy regional burden of head and neck cancers in South and Southeast Asia. According to GLOBOCAN 2022 estimates published by the International Agency for Research on Cancer, lip and oral cavity cancers accounted for 389,846 new cases and 188,438 deaths globally that year. In India alone, lip and oral cavity cancer ranked as the most frequently diagnosed cancer among men in 2022, totaling an estimated 107,812 new cases.
While tobacco, betel quid, and alcohol use remain widespread background factors in South Asian cohorts, distinct molecular features like p16 overexpression require careful clinical interpretation. The study shows that while p16 immunohistochemistry supplies useful supplementary data, it must be treated as a surrogate marker rather than definitive proof of HPV-driven pathology without dedicated molecular confirmation.
References
- International Agency for Research on Cancer (IARC). GLOBOCAN 2022: Lip and Oral Cavity Cancer Estimates. World Health Organization.
- Clinicopathological Analysis of 1,000 Cases of Head and Neck Squamous Cell Carcinoma With Special Emphasis on Histological Variants and p16 Expression. Government ENT Hospital, Osmania Medical College, Hyderabad.
